Boehringer Ingelheim Pharma GmbH & Co. KG (manufacturing, primary and secondary packaging, quality control, batch release)/PATEON FRANCE (primary and secondary packaging, quality control, batch release)
UkraineAll drugs from this manufacturer
-
The drug is intended for adults and children aged 10 years and older for the treatment of type 2 diabetes mellitus as an adjunct to diet and exercise, if other agents are insufficient to control blood sugar levels.
Dosage form: tablets, film-coated
Active substance Dosage empagliflozin 5 mg metformin 1000 mg ATC: A10BD20
-
The drug is intended for adults and children aged 10 years and older for the treatment of type 2 diabetes. It is used as an adjunct to diet and exercise if metformin or other agents do not provide adequate blood sugar control.
Dosage form: tablets, film-coated
Active substance Dosage empagliflozin 12.5 mg metformin 1000 mg ATC: A10BD20